$199 Million is the total value of Pivotal bioVenture Partners Investment Advisor LLC's 11 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RALLYBIO CORP | $17,148,000 | +8.2% | 2,271,311 | 0.0% | 8.64% | +15.2% | ||
ARQT | ARCUTIS BIOTHERAPEUTICS INC | $12,126,000 | +10.6% | 569,041 | 0.0% | 6.11% | +17.8% | |
AKUS | AKOUOS INC | $8,414,000 | -1.3% | 1,794,088 | 0.0% | 4.24% | +5.1% | |
EXSCIENTIA PLCads | $8,410,000 | -24.4% | 772,285 | 0.0% | 4.24% | -19.5% | ||
BOLT | BOLT BIOTHERAPEUTICS INC | $3,859,000 | -25.5% | 1,891,467 | 0.0% | 1.94% | -20.7% | |
VIGIL NEUROSCIENCE INC | $1,446,000 | -63.3% | 560,595 | 0.0% | 0.73% | -61.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
KARUNA THERAPEUTICS INC | 12 | Q3 2023 | 65.4% |
VAXCYTE INC | 12 | Q3 2023 | 19.5% |
INOZYME PHARMA INC | 12 | Q3 2023 | 10.8% |
ARCUTIS BIOTHERAPEUTICS INC | 12 | Q3 2023 | 6.2% |
FUSION PHARMACEUTICALS INC | 12 | Q3 2023 | 6.2% |
ALIGOS THERAPEUTICS INC | 12 | Q3 2023 | 8.0% |
BOLT BIOTHERAPEUTICS INC | 11 | Q3 2023 | 20.0% |
RALLYBIO CORP | 9 | Q3 2023 | 14.1% |
AKOUOS INC | 8 | Q3 2022 | 11.7% |
EXSCIENTIA PLC | 8 | Q3 2023 | 6.4% |
View Pivotal bioVenture Partners Investment Advisor LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Pivotal bioVenture Partners Investment Advisor LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.